Highlights

Recent analysis suggests a significant likelihood of approval for ETFs focusing on Litecoin, XRP, and Dogecoin, with chances reaching over 90% for Litecoin. These predictions come amid changing U.S. regulatory dynamics that favor cryptocurrency exchange-traded funds, with expectations for major tokens like Solana and Ripple products soon to follow.

Sentiment Analysis

• Positive outlook on the approval of cryptocurrency ETFs due to regulatory changes in the U.S.


• Strong growth observed in cryptocurrency values, especially Litecoin and Dogecoin.


• Concerns persist about potential appeals impacting XRP.

Article Text

The probability of launching an exchange-traded fund (ETF) for Litecoin (LTC) has significantly increased, reaching over 90% according to recent predictions by James Seyffart, a well-known ETF analyst. Dogecoin (DOGE) follows closely, with a 75% chance of an ETF approval soon. This forecast was shared by Seyffart in a late Monday post, resonating with previous predictions he made for Bitcoin (BTC) ETFs before they debuted in 2024.

Under the Biden administration, several firms have filed for ETFs for major cryptocurrencies, although interest from the U.S. Securities and Exchange Commission (SEC) remained tepid until recent regulatory shifts. Litecoin showed a remarkable 15% increase over the past day, surpassing Bitcoin's 2% rise, and Dogecoin improved by 6%.

The evolving regulatory landscape supports optimism for crypto ETF approvals, especially as the SEC progresses through initial evaluations for certain tokens. Seyffart from Bloomberg Intelligence is optimistic about the approval of ETFs primarily centered on Litecoin, Solana, XRP, and Dogecoin, with XRP and Dogecoin filings expected to be acknowledged soon.

He observed that under previous Democratic control, the odds for these approvals would have been considerably lower. Litecoin ETFs could potentially attract up to $580 million in investments if adopted with enthusiasm similar to Bitcoin ETFs. Prospective XRP and SOL products are currently estimated at under 70% approval chance, dealing with challenges like possible appeals from the SEC’s resolved case against Ripple Labs.

Key Insights Table